A Phase III Superiority Study of Vernakalant vs Amiodarone in Subjects With Recent Onset Atrial Fibrillation
NCT00668759
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
254
Enrollment
INDUSTRY
Sponsor class
Conditions
Atrial Fibrillation
Interventions
DRUG:
Vernakalant Injection
DRUG:
Amiodarone Injection:
Sponsor
Advanz Pharma